Hiring?
Logo

S.T.E.P.S.

location_on

North East,

Short Summary

S.T.E.P.S (Service Techniques Empowering People with Support) is a group home agency that provides community living homes for adults with intellectual and developmental disabilities. As owners, we have 26 combined years of field experience.

Overview

Target
US$500,000
Minimum
US$50,000
Investment Raised
N/A
Previous Rounds N/A
Stage MVP/Finished Product
Investor Role Silent

Highlights

  • Our agency will be ready to begin providing services in a few short months.
  • We are experienced and have great relationships in the profession.
  • We will receive fixed payment rates from the state.
  • 40% annual return on investment after the first year.
  • Double your investment in 6 years.
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Global Pro
0% raised

New COVID-19 Test

location_on West, USA

We at American Made DiagnoStiks® have developed the IQStik®, a saliva-based COVID-19 test that can deliver results in just 5 minutes. We're looking for angel investors to help fund the mass production of the IQStik® for global distribution.

US$ 10,000,000

Target

US$ 50,000

Min per Investor

Global Pro
0% raised

QuadVantage

location_on Midwest, USA

New Gold Standard: Transforming ACL Reconstruction Surgery: Superior strength · Reduced pain · Improved aesthetics · Reduced rehabilitation - Patented, Clinically tested technology. No additional FDA clearance required.

US$ 1,000,000

Target

US$ 100,000

Min per Investor

Pro
0% raised

Pyogenix

location_on Midwest, USA

Pyogenix; Improving the specificity & sensitivity of clinical pathogen detection while simultaneously reducing time to identification; Invited by NSF to submit Phase I SBIR grant; Great feedback from potential clients & ID physicians; $13.93bn market

US$ 250,000

Target

US$ 25,000

Min per Investor

load one similar proposal